Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Related Articles by Review for PubMed (Select 15623441)

1.

F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.

Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S.

J Gastrointest Surg. 2005 Jan;9(1):22-8; discussion 28-9.

PMID:
15623441
2.

Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality".

Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, Imamura M, Konishi J.

Ann Nucl Med. 2003 Jun;17(4):261-79. Review.

PMID:
12932109
3.

[The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].

Voth M, Opfermann T, Gottschild D.

Zentralbl Chir. 2003 May;128(5):375-8. Review. German.

PMID:
12813634
4.

[Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].

Zimny M, Schumpelick V.

Chirurg. 2001 Sep;72(9):989-94. Review. German.

PMID:
11594284
5.

Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.

Guan ZW, Xu BX, Wang RM, Sun L, Tian JH.

Hell J Nucl Med. 2013 May-Aug;16(2):97-102. doi: 10.1967/s002449910084. Epub 2013 May 20. Review.

6.

Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.

Pery C, Meurette G, Ansquer C, Frampas E, Regenet N.

Gastroenterol Clin Biol. 2010 Sep;34(8-9):465-74. doi: 10.1016/j.gcb.2009.04.014. Epub 2010 Aug 4. Review.

7.

Imaging of indeterminate pancreatic cystic lesions: a systematic review.

Jones MJ, Buchanan AS, Neal CP, Dennison AR, Metcalfe MS, Garcea G.

Pancreatology. 2013 Jul-Aug;13(4):436-42. doi: 10.1016/j.pan.2013.05.007. Epub 2013 Jun 4. Review.

PMID:
23890144
8.

The role of PET scanning in pancreatic cancer.

Serrano OK, Chaudhry MA, Leach SD.

Adv Surg. 2010;44:313-25. Review.

PMID:
20919529
9.

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.

Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD.

Ann Surg. 1999 May;229(5):729-37; discussion 737-8. Review.

10.

Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis.

Rijkers AP, Valkema R, Duivenvoorden HJ, van Eijck CH.

Eur J Surg Oncol. 2014 Jul;40(7):794-804. doi: 10.1016/j.ejso.2014.03.016. Epub 2014 Apr 3. Review.

PMID:
24755095
11.

Metabolic imaging with FDG: a primer.

Delbeke D, Martin WH.

Cancer J. 2004 Jul-Aug;10(4):201-13. Review.

PMID:
15383201
12.

Positron emission tomography in the diagnosis of mesothelioma.

Haberkorn U.

Lung Cancer. 2004 Aug;45 Suppl 1:S73-6. Review.

PMID:
15261438
13.

Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.

Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Bertagna F, Prior JO, Ceriani L, Giovanella L.

Acad Radiol. 2014 Jan;21(1):11-20. doi: 10.1016/j.acra.2013.09.015. Review.

PMID:
24331260
14.

F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature.

Bertagna F, Treglia G, Baiocchi GL, Giubbini R.

Jpn J Radiol. 2013 Apr;31(4):229-36. doi: 10.1007/s11604-012-0176-2. Epub 2013 Jan 12. Review.

PMID:
23315020
15.

Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.

De Gaetano AM, Rufini V, Castaldi P, Gatto AM, Filograna L, Giordano A, Bonomo L.

Abdom Imaging. 2012 Dec;37(6):983-1003. doi: 10.1007/s00261-012-9845-y. Review.

PMID:
22527152
16.

Advances in imaging for pancreatic disease.

Del Frate C, Zanardi R, Mortele K, Ros PR.

Curr Gastroenterol Rep. 2002 Apr;4(2):140-8. Review.

PMID:
11900679
17.

[(18)F]-FDG PET and localized fibrous mesothelioma.

Cortes J, Rodriguez J, Garcia-Velloso MJ, Rodriguez-Espiteri N, Boan JF, Castellano JM, Torre W.

Lung. 2003;181(1):49-54. Review.

PMID:
12879339
18.

Positron emission tomography imaging in oncology.

Delbeke D, Martin WH.

Radiol Clin North Am. 2001 Sep;39(5):883-917. Review.

PMID:
11587060
19.

Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.

Liu Y.

Nucl Med Commun. 2011 Jul;32(7):554-62. doi: 10.1097/MNM.0b013e328345b984. Review.

PMID:
21403583
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk